HEADER TRANSFERASE 27-MAR-02 1GX4 TITLE ALPHA-,1,3 GALACTOSYLTRANSFERASE - N-ACETYL LACTOSAMINE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN RESIDUES 80-368; COMPND 5 SYNONYM: GALACTOSYLTRANSFERASE, UDP-GALACTOSE\: BETA-D-GALACTOSYL-1, COMPND 6 4-N-ACETYL-D-GLUCOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE; COMPND 7 EC: 2.4.1.151; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 668369; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: DH5ALPHA; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PSV-SPORT KEYWDS GALACTOSYLTRANSFERASE, BLOOD GROUP SUGARS, LACTOSE, N-ACETYL KEYWDS 2 LACTOSAMINE, TRANSFERASE, GLYCOSYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.BOIX,Y.ZHANG,G.J.SWAMINATHAN,K.BREW,K.R.ACHARYA REVDAT 7 08-MAY-24 1GX4 1 HETSYN REVDAT 6 29-JUL-20 1GX4 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 22-MAY-19 1GX4 1 REMARK REVDAT 4 07-SEP-11 1GX4 1 COMPND SOURCE REMARK HETSYN REVDAT 4 2 1 FORMUL SITE HETATM ANISOU REVDAT 4 3 1 CONECT VERSN REVDAT 3 24-FEB-09 1GX4 1 VERSN REVDAT 2 18-JUL-03 1GX4 1 REMARK REVDAT 1 27-MAR-03 1GX4 0 JRNL AUTH E.BOIX,Y.ZHANG,G.J.SWAMINATHAN,K.BREW,K.R.ACHARYA JRNL TITL STRUCTURAL BASIS OF ORDERED BINDING OF DONOR AND ACCEPTOR JRNL TITL 2 SUBSTRATES TO THE RETAINING GLYCOSYLTRANSFERASE, ALPHA -1,3 JRNL TITL 3 GALACTOSYLTRANSFERASE JRNL REF J.BIOL.CHEM. V. 277 28310 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 12011052 JRNL DOI 10.1074/JBC.M202631200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.BOIX,G.J.SWAMINATHAN,Y.ZHANG,R.NATESH,K.BREW,K.R.ACHARYA REMARK 1 TITL STRUCTURE OF UDP COMPLEX OF REMARK 1 TITL 2 UDP-GALACTOSE:BETA-GALACTOSIDE-ALPHA REMARK 1 TITL 3 -1,3-GALACTOSYLTRANSFERASE AT 1. 53-A RESOLUTION REVEALS A REMARK 1 TITL 4 CONFORMATIONAL CHANGE IN THE CATALYTICALLY IMPORTANT C REMARK 1 TITL 5 TERMINUS. REMARK 1 REF J.BIOL.CHEM. V. 276 48608 2001 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 11592969 REMARK 1 DOI 10.1074/JBC.M108828200 REMARK 2 REMARK 2 RESOLUTION. 1.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.46 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.151 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.149 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4027 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 128321 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.129 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.127 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.172 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3218 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 102754 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4778 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 128 REMARK 3 SOLVENT ATOMS : 773 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 5669.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 25 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 50698 REMARK 3 NUMBER OF RESTRAINTS : 61372 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 ANGLE DISTANCES (A) : 0.024 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.030 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.057 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.058 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.011 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.003 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.051 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.086 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY 4.2% REMARK 4 REMARK 4 1GX4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-MAR-02. REMARK 100 THE DEPOSITION ID IS D_1290009624. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 132382 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.460 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.46 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.51 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.43400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.030 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6000, TRIS/HCL, PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.62250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYSES THE TRANSFER OF GALACTOSE FROM UDP-GALACTOSE TO AN REMARK 400 ACCEPTOR MOLECULE. REMARK 400 UDP-GALACTOSE + BETA-D-GALACTOSYL-(1,4)-N- REMARK 400 ACETYL-D-GLUCOSAMINYL-R = UDP + ALPHA-D-GALACTOSYL-(1,3)-BETA-D- REMARK 400 GALACTOSYL-(1,4)-N-ACETYL-D-GLUCOSAMINYL-R. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 80 REMARK 465 SER A 81 REMARK 465 GLU B 80 REMARK 465 SER B 81 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 82 CG CD CE NZ REMARK 470 LYS B 82 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 172 NE - CZ - NH1 ANGL. DEV. = -9.0 DEGREES REMARK 500 ARG A 172 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 TYR A 260 CB - CG - CD2 ANGL. DEV. = 4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 213 -39.04 -151.48 REMARK 500 THR A 259 48.28 -84.45 REMARK 500 HIS A 315 -130.19 53.66 REMARK 500 CYS A 338 80.49 -163.77 REMARK 500 HIS B 213 -37.72 -148.81 REMARK 500 THR B 259 47.34 -86.26 REMARK 500 HIS B 315 -131.68 55.91 REMARK 500 CYS B 338 82.47 -162.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 880 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A 881 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH A 882 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH B 888 DISTANCE = 5.94 ANGSTROMS REMARK 525 HOH B 889 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH B 890 DISTANCE = 6.58 ANGSTROMS REMARK 525 HOH B 891 DISTANCE = 6.91 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 402 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 225 OD2 REMARK 620 2 ASP A 227 OD1 97.9 REMARK 620 3 ASP A 227 OD2 152.1 54.6 REMARK 620 4 UDP A 401 O1A 93.6 84.4 80.5 REMARK 620 5 UDP A 401 O1B 100.5 161.0 106.6 89.7 REMARK 620 6 HOH A 674 O 95.9 99.7 93.6 169.1 83.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN B 402 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 225 OD2 REMARK 620 2 ASP B 227 OD1 97.2 REMARK 620 3 ASP B 227 OD2 151.7 54.8 REMARK 620 4 UDP B 401 O1A 92.9 83.9 81.3 REMARK 620 5 UDP B 401 O1B 99.5 162.4 108.0 89.6 REMARK 620 6 HOH B 645 O 98.1 99.9 91.4 167.8 83.3 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FG5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BOVINE ALPHA-1,3- REMARK 900 GALACTOSYLTRANSFERASECATALYTIC DOMAIN. REMARK 900 RELATED ID: 1G8O RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC STRUCTURE OF THE NATIVE BOVINE ALPHA-1,3- REMARK 900 GALACTOSYLTRANSFERASE CATALYTIC DOMAIN REMARK 900 RELATED ID: 1G93 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE BOVINE CATALYTIC DOMAIN OF ALPHA-1,3- REMARK 900 GALACTOSYLTRANSFERASE IN THE PRESENCE OF UDP-GALACTOSE REMARK 900 RELATED ID: 1GWW RELATED DB: PDB REMARK 900 ALPHA-,1,3 GALACTOSYLTRANSFERASE - ALPHA-D-GLUCOSE COMPLEX REMARK 900 RELATED ID: 1GWV RELATED DB: PDB REMARK 900 ALPHA-,1,3 GALACTOSYLTRANSFERASE - LACTOSE COMPLEX REMARK 900 RELATED ID: 1GX0 RELATED DB: PDB REMARK 900 ALPHA-,1,3 GALACTOSYLTRANSFERASE - BETA-D-GALACTOSE COMPLEX REMARK 900 RELATED ID: 1K4V RELATED DB: PDB REMARK 900 1.53 A CRYSTAL STRUCTURE OF THE BETA- GALACTOSIDE-ALPHA-1,3- REMARK 900 GALACTOSYLTRANSFERASE IN COMPLEX WITH UDP REMARK 900 RELATED ID: 1O7O RELATED DB: PDB REMARK 900 ROLES OF INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN REMARK 900 SUBSTRATE BINDING AND CATALYSIS REMARK 900 RELATED ID: 1O7Q RELATED DB: PDB REMARK 900 ROLES OF INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN REMARK 900 SUBSTRATE BINDING AND CATALYSIS REMARK 900 RELATED ID: 1O7R RELATED DB: PDB REMARK 900 ROLES ON INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN REMARK 900 SUBSTRATE BINDING AND CATALYSIS DBREF 1GX4 A 80 368 UNP P14769 GATR_BOVIN 80 368 DBREF 1GX4 B 80 368 UNP P14769 GATR_BOVIN 80 368 SEQRES 1 A 289 GLU SER LYS LEU LYS LEU SER ASP TRP PHE ASN PRO PHE SEQRES 2 A 289 LYS ARG PRO GLU VAL VAL THR MET THR LYS TRP LYS ALA SEQRES 3 A 289 PRO VAL VAL TRP GLU GLY THR TYR ASN ARG ALA VAL LEU SEQRES 4 A 289 ASP ASN TYR TYR ALA LYS GLN LYS ILE THR VAL GLY LEU SEQRES 5 A 289 THR VAL PHE ALA VAL GLY ARG TYR ILE GLU HIS TYR LEU SEQRES 6 A 289 GLU GLU PHE LEU THR SER ALA ASN LYS HIS PHE MET VAL SEQRES 7 A 289 GLY HIS PRO VAL ILE PHE TYR ILE MET VAL ASP ASP VAL SEQRES 8 A 289 SER ARG MET PRO LEU ILE GLU LEU GLY PRO LEU ARG SER SEQRES 9 A 289 PHE LYS VAL PHE LYS ILE LYS PRO GLU LYS ARG TRP GLN SEQRES 10 A 289 ASP ILE SER MET MET ARG MET LYS THR ILE GLY GLU HIS SEQRES 11 A 289 ILE VAL ALA HIS ILE GLN HIS GLU VAL ASP PHE LEU PHE SEQRES 12 A 289 CYS MET ASP VAL ASP GLN VAL PHE GLN ASP LYS PHE GLY SEQRES 13 A 289 VAL GLU THR LEU GLY GLU SER VAL ALA GLN LEU GLN ALA SEQRES 14 A 289 TRP TRP TYR LYS ALA ASP PRO ASN ASP PHE THR TYR GLU SEQRES 15 A 289 ARG ARG LYS GLU SER ALA ALA TYR ILE PRO PHE GLY GLU SEQRES 16 A 289 GLY ASP PHE TYR TYR HIS ALA ALA ILE PHE GLY GLY THR SEQRES 17 A 289 PRO THR GLN VAL LEU ASN ILE THR GLN GLU CYS PHE LYS SEQRES 18 A 289 GLY ILE LEU LYS ASP LYS LYS ASN ASP ILE GLU ALA GLN SEQRES 19 A 289 TRP HIS ASP GLU SER HIS LEU ASN LYS TYR PHE LEU LEU SEQRES 20 A 289 ASN LYS PRO THR LYS ILE LEU SER PRO GLU TYR CYS TRP SEQRES 21 A 289 ASP TYR HIS ILE GLY LEU PRO ALA ASP ILE LYS LEU VAL SEQRES 22 A 289 LYS MET SER TRP GLN THR LYS GLU TYR ASN VAL VAL ARG SEQRES 23 A 289 ASN ASN VAL SEQRES 1 B 289 GLU SER LYS LEU LYS LEU SER ASP TRP PHE ASN PRO PHE SEQRES 2 B 289 LYS ARG PRO GLU VAL VAL THR MET THR LYS TRP LYS ALA SEQRES 3 B 289 PRO VAL VAL TRP GLU GLY THR TYR ASN ARG ALA VAL LEU SEQRES 4 B 289 ASP ASN TYR TYR ALA LYS GLN LYS ILE THR VAL GLY LEU SEQRES 5 B 289 THR VAL PHE ALA VAL GLY ARG TYR ILE GLU HIS TYR LEU SEQRES 6 B 289 GLU GLU PHE LEU THR SER ALA ASN LYS HIS PHE MET VAL SEQRES 7 B 289 GLY HIS PRO VAL ILE PHE TYR ILE MET VAL ASP ASP VAL SEQRES 8 B 289 SER ARG MET PRO LEU ILE GLU LEU GLY PRO LEU ARG SER SEQRES 9 B 289 PHE LYS VAL PHE LYS ILE LYS PRO GLU LYS ARG TRP GLN SEQRES 10 B 289 ASP ILE SER MET MET ARG MET LYS THR ILE GLY GLU HIS SEQRES 11 B 289 ILE VAL ALA HIS ILE GLN HIS GLU VAL ASP PHE LEU PHE SEQRES 12 B 289 CYS MET ASP VAL ASP GLN VAL PHE GLN ASP LYS PHE GLY SEQRES 13 B 289 VAL GLU THR LEU GLY GLU SER VAL ALA GLN LEU GLN ALA SEQRES 14 B 289 TRP TRP TYR LYS ALA ASP PRO ASN ASP PHE THR TYR GLU SEQRES 15 B 289 ARG ARG LYS GLU SER ALA ALA TYR ILE PRO PHE GLY GLU SEQRES 16 B 289 GLY ASP PHE TYR TYR HIS ALA ALA ILE PHE GLY GLY THR SEQRES 17 B 289 PRO THR GLN VAL LEU ASN ILE THR GLN GLU CYS PHE LYS SEQRES 18 B 289 GLY ILE LEU LYS ASP LYS LYS ASN ASP ILE GLU ALA GLN SEQRES 19 B 289 TRP HIS ASP GLU SER HIS LEU ASN LYS TYR PHE LEU LEU SEQRES 20 B 289 ASN LYS PRO THR LYS ILE LEU SER PRO GLU TYR CYS TRP SEQRES 21 B 289 ASP TYR HIS ILE GLY LEU PRO ALA ASP ILE LYS LEU VAL SEQRES 22 B 289 LYS MET SER TRP GLN THR LYS GLU TYR ASN VAL VAL ARG SEQRES 23 B 289 ASN ASN VAL HET NAG C 1 17 HET GAL C 2 11 HET NAG D 1 15 HET GAL D 2 11 HET UDP A 401 25 HET MN A 402 1 HET GOL A 405 6 HET GOL A 406 6 HET GOL A 407 6 HET UDP B 401 25 HET MN B 402 1 HET GOL B 405 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM UDP URIDINE-5'-DIPHOSPHATE HETNAM MN MANGANESE (II) ION HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 5 UDP 2(C9 H14 N2 O12 P2) FORMUL 6 MN 2(MN 2+) FORMUL 7 GOL 4(C3 H8 O3) FORMUL 13 HOH *773(H2 O) HELIX 1 AA1 LYS A 84 PHE A 89 1 6 HELIX 2 AA2 ASN A 90 ARG A 94 5 5 HELIX 3 AA3 ASN A 114 LYS A 126 1 13 HELIX 4 AA4 ARG A 138 PHE A 155 1 18 HELIX 5 AA5 ASP A 169 MET A 173 5 5 HELIX 6 AA6 ARG A 194 HIS A 213 1 20 HELIX 7 AA7 HIS A 213 VAL A 218 1 6 HELIX 8 AA8 GLY A 235 LEU A 239 5 5 HELIX 9 AA9 ASP A 254 PHE A 258 5 5 HELIX 10 AB1 THR A 287 ASN A 308 1 22 HELIX 11 AB2 TRP A 314 ASN A 327 1 14 HELIX 12 AB3 PRO A 335 CYS A 338 5 4 HELIX 13 AB4 ASP A 340 GLY A 344 5 5 HELIX 14 AB5 GLU A 360 ARG A 365 1 6 HELIX 15 AB6 LYS B 84 TRP B 88 5 5 HELIX 16 AB7 ASN B 90 ARG B 94 5 5 HELIX 17 AB8 ASN B 114 LYS B 126 1 13 HELIX 18 AB9 ARG B 138 PHE B 155 1 18 HELIX 19 AC1 ASP B 169 MET B 173 5 5 HELIX 20 AC2 ARG B 194 HIS B 213 1 20 HELIX 21 AC3 HIS B 213 VAL B 218 1 6 HELIX 22 AC4 GLY B 235 LEU B 239 5 5 HELIX 23 AC5 ASP B 254 PHE B 258 5 5 HELIX 24 AC6 THR B 287 ASN B 308 1 22 HELIX 25 AC7 TRP B 314 ASN B 327 1 14 HELIX 26 AC8 PRO B 335 CYS B 338 5 4 HELIX 27 AC9 ASP B 340 GLY B 344 5 5 HELIX 28 AD1 GLU B 360 ARG B 365 1 6 SHEET 1 AA1 8 VAL A 107 VAL A 108 0 SHEET 2 AA1 8 LYS A 331 LEU A 333 1 O ILE A 332 N VAL A 108 SHEET 3 AA1 8 SER A 242 LEU A 246 1 N ALA A 244 O LEU A 333 SHEET 4 AA1 8 TYR A 279 GLY A 286 -1 O GLY A 285 N VAL A 243 SHEET 5 AA1 8 PHE A 220 MET A 224 -1 N CYS A 223 O PHE A 284 SHEET 6 AA1 8 VAL A 129 ALA A 135 1 N GLY A 130 O PHE A 220 SHEET 7 AA1 8 VAL A 161 VAL A 167 1 O TYR A 164 N LEU A 131 SHEET 8 AA1 8 ARG A 182 LYS A 188 1 O PHE A 187 N ILE A 165 SHEET 1 AA2 2 GLN A 228 PHE A 230 0 SHEET 2 AA2 2 MET A 354 TRP A 356 -1 O SER A 355 N VAL A 229 SHEET 1 AA3 8 VAL B 107 VAL B 108 0 SHEET 2 AA3 8 LYS B 331 LEU B 333 1 O ILE B 332 N VAL B 108 SHEET 3 AA3 8 SER B 242 GLN B 245 1 N ALA B 244 O LEU B 333 SHEET 4 AA3 8 ILE B 283 GLY B 286 -1 O GLY B 285 N VAL B 243 SHEET 5 AA3 8 PHE B 220 MET B 224 -1 N CYS B 223 O PHE B 284 SHEET 6 AA3 8 VAL B 129 ALA B 135 1 N GLY B 130 O PHE B 220 SHEET 7 AA3 8 VAL B 161 VAL B 167 1 O TYR B 164 N LEU B 131 SHEET 8 AA3 8 ARG B 182 LYS B 188 1 O LYS B 185 N ILE B 165 SHEET 1 AA4 2 GLN B 228 PHE B 230 0 SHEET 2 AA4 2 MET B 354 TRP B 356 -1 O SER B 355 N VAL B 229 LINK O4 NAG C 1 C1 GAL C 2 1555 1555 1.43 LINK O4 NAG D 1 C1 GAL D 2 1555 1555 1.44 LINK OD2 ASP A 225 MN MN A 402 1555 1555 2.18 LINK OD1 ASP A 227 MN MN A 402 1555 1555 2.21 LINK OD2 ASP A 227 MN MN A 402 1555 1555 2.49 LINK O1A UDP A 401 MN MN A 402 1555 1555 2.24 LINK O1B UDP A 401 MN MN A 402 1555 1555 2.17 LINK MN MN A 402 O HOH A 674 1555 1555 2.24 LINK OD2 ASP B 225 MN MN B 402 1555 1555 2.18 LINK OD1 ASP B 227 MN MN B 402 1555 1555 2.23 LINK OD2 ASP B 227 MN MN B 402 1555 1555 2.52 LINK O1A UDP B 401 MN MN B 402 1555 1555 2.27 LINK O1B UDP B 401 MN MN B 402 1555 1555 2.10 LINK MN MN B 402 O HOH B 645 1555 1555 2.21 CRYST1 45.626 95.245 95.638 90.00 99.09 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021917 0.000000 0.003507 0.00000 SCALE2 0.000000 0.010499 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010589 0.00000